Patent Baristas

I received a note from the USPTO asking if I could post a notice about needing volunteers for a Complex Work Units Pilot Program.  This is mainly for those that deal with complex chemical or mathmatical formulae. The United States Patent and Trademark Office (USPTO) is seeking participants for a Complex Work Units (CWUs) Pilot […]

As further evidence that the United States Patent and Trademark Office (Office) hates the chemical/pharma/biotech arts, the Office is proposing to revise the rules of practice pertaining to any claim using alternative language to claim one or more species. That is, if the claims use Markush or other forms of alternative language. This is all […]

Sheryl Sisk Schelin, a solo practitioner living and working in North Myrtle Beach, South Carolina (yes, we hate her already), brings an inspired version of Blawg Review this week in Blawg Review #121 over at the Inspired Solo. We especially enjoyed David Lat’s post on Above the Law regarding a counsel’s motion to reschedule oral […]

Johnson & Johnson has sued the American Red Cross, an indisputably highly regarded charitable organization, over ARC’s “commercial” use of the red cross symbol trademark. It seems that the ARC has been licensing others to use the symbol in connection with first-aid type products sold in retail stores. To raise money, of course. That’s generally […]

The Position: CincyTechUSA is looking for a Bioscience Executive-in-Residence to identify new technologies that have the potential to be commercialized through the formation of new companies; guide the launch these startups; prepare startups for an investment from CincyTech’s Seed Fund; and work with companies to help them achieve investment milestones and attract a follow on […]

Kurt Karst of the FDA Law Blog ran a nice update on patent term extension (PTE) legislation. The legislation, known as the “Dog Ate My Homework Act,” would permit the U.S. Patent and Trademark Office to exercise discretion to accept untimely filed Patent Term Extension (PTE) applications has been added to the Patent Reform Act […]

In a follow-up on our earlier discussion regarding the Supreme Court’s broad scope of the research exemption to the Integra case, the question came up asking if a patented delivery formulation — say, a sustained release formulation as opposed to a therapeutic itself — would fall within the exemption from infringement under the Food and […]

In a nonprecedential decision, the U.S. Court of Appeals for the Federal Circuit held that it won’t force the United States Patent and Trademark Office (USPTO) to issue a decision absent the authority to act. Somerset Pharmaceuticals v. Dudas (07-1447). Somerset tried appealing from district court, which turned down its request to get the Director […]